Aqvesme is expected to be available in late January 2026. The Food and Drug Administration (FDA) has approved Aqvesme™ (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia ...
Company will host investor conference call and webcast tomorrow, December 24 at 8:00 a.m. ET CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (AGIO), a commercial-stage ...
I have been on a quest: I'm seeking alpha. That's not a joke. We all are. And while most of my articles here are "top-down" in nature, talking about the broader index trends for the S&P 500, this time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results